Faculty profile

Aslam Anis

ResearcherSchool of Population and Public HealthUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Aslam Anis

Researcher

School of Population and Public Health

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
4 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 12 research grants (12 CIHR), most recently in 2021.
Supervisor on 3 trainee awards (3 CIHR), most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hiv Hcv Pharmaceutical Policy Antiretroviral Therapy Co-Infection Immunomodulators Multicentre Research Prevention

Latest papers

The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.
Pharmacoepidemiology and drug safety · 2026
Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves
AIDS · 2024
COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis.
Journal of the International AIDS Society · 2023

All 28 publications

Latest funding

Evaluating and Informing Canada's Proposed Pharmaceutical Price Regulations
CIHR · 2021 · Nominated PI
$581,400
COVID-19 And Severe Community-Acquired Pneumonia Dynamic Evaluation Study (CASCADES - ARBS CORONA III)
CIHR · 2021 · Co-investigator
$500,000
Evaluating the impact of a mandatory switching policy for biosimilars
CIHR · 2020 · Co-investigator
$298,350

All 23 grants and awards

28 publications.

The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.

Harrison M, Blitz S, Law M, Tadrous M, Gomes T, Clement F, Rosenfeld G, Anis A, Bansback N

Pharmacoepidemiology and drug safety2026

DOI: 10.1002/pds.70395 PMID: 42157439

Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves

Chambers C, Cooper CL, Kroch AE, Buchan SA, Kendall CE, Kwong JC, Moideddin R, Nguyen L, Arbess G, Benoit AC

AIDS20242 citations

DOI: 10.1097/qad.0000000000003922

COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis.

Puyat JH, Wilton J, Fowokan A, Janjua NZ, Wong J, Grennan T, Chambers C, Kroch A, Costiniuk CT, Cooper CL, Lauscher D, Strong M, Burchell AN, Anis A, Samji H, COVAXHIV Study Team

Journal of the International AIDS Society2023

DOI: 10.1002/jia2.26178 PMID: 37885156

Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design.

Fowokan A, Samji H, Puyat JH, Janjua NZ, Wilton J, Wong J, Grennan T, Chambers C, Kroch A, Costiniuk CT, Cooper CL, Burchell AN, Anis A, COVAXHIV study team

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2023Senior author

DOI: 10.1016/j.ijid.2022.11.035 PMID: 36462571

When does the use of individual patient data in network meta-analysis make a difference? A simulation study

Kanters S, Karim ME, Thorlund K, Anis A, Bansback N

BMC Medical Research Methodology202121 citationsOpen Access

DOI: 10.1186/s12874-020-01198-2 PMID: W3119616871

Patient-provider communication about medication cost in rheumatoid arthritis.

Kaal KJ, Bansback N, Hudson M, Anis A, Koehn C, Harrison M

Clinical rheumatology2021

DOI: 10.1007/s10067-020-05188-z PMID: 32506315

Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.

Harvard S, Guh D, Bansback N, Richette P, Saraux A, Fautrel B, Anis A

Cost effectiveness and resource allocation : C/E2017Senior author

DOI: 10.1186/s12962-017-0081-8 PMID: 28904528

Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort.

Harvard S, Guh D, Bansback N, Richette P, Dougados M, Anis A, Fautrel B

RMD open2016

DOI: 10.1136/rmdopen-2015-000230 PMID: 27099778

Measurable definitions of ankylosing spondylitis management recommendations are needed for use in observational studies.

Harvard S, Gossec L, Pham T, Richette P, Dougados M, Anis A, Fautrel B

Joint bone spine2016

DOI: 10.1016/j.jbspin.2015.01.019 PMID: 25776447

Making smart investment decisions in clinical research.

Bansback N, Keystone E, O'Dell J, Phibbs CS, Hannagan K, Brophy M, Anis A

Trials2015Senior author

DOI: 10.1186/s13063-015-1123-1 PMID: 26712327

Something wrong or missing on this profile? Suggest a correction

Aslam Anis

Research

Latest papers

Latest funding

The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.

Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves

COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis.

Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design.

When does the use of individual patient data in network meta-analysis make a difference? A simulation study

Patient-provider communication about medication cost in rheumatoid arthritis.

Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.

Costs of early spondyloarthritis: estimates from the first 3&#x2005;years of the DESIR cohort.

Measurable definitions of ankylosing spondylitis management recommendations are needed for use in observational studies.

Making smart investment decisions in clinical research.

Frequent collaborators

Eugenia Oviedo-Joekes

Bohdan Nosyk

Carlo Marra

Mark Harrison

Hasina Samji

Hasina Samji

Catharine Chambers

Jason Wong

Abigail Kroch

Wei Zhang

Jill Chettiar

Kirsten Marchand

Hubert Wong

Cheryl Koehn

Jacek Kopec

Sergio Rueda

Darren Lauscher

Marco Marra

Tara Gomes

Eric Grafstein

Gordon Arbess

Lawrence Mbuagbaw

Stirling Bryan

Kristian Thorlund

Michael Law

Marie Hudson

Fiona Clement

Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort.